Advertising Information and Links

Article Navigation

Click Here for more articles

Site Map
Contact Us
About Us
Blog

Place Ads-Publish Articles
Place ads, publish articles and do it with a partner. The quick and easy way to make money online! Aticles are quite easy once you have done a couple, unless you like to write then it is easy from the start. Click Here,for more information on article marketing, and useing articles for your advertising resources!

PPC Advertising!
Pay per click advertising is a very good money making tool. learn how you can make over 100,000 a month with pay per click,or adwords. When you use pay per click advertising you have control of your ads.To learn about how you can use pay per click ads and make money,Click here! Use these ppc ads to advertise your own site or advertise other sites and make a commission for your efforts!

Peel Away Ads
Peel away ads let you get your customers attention without getting under there skin, like with pop-ups and fly-ins. Peel away ads are polite way of saying click here! With peel away ads the customer has to make the move to the ad, this way the customer remains calm and will stay on the page! To have a look at a peel away ad, come and see us Here!

Searchbyu.com Advertising
Searchbyu.com is simmilar to ppc ad only you have a set price for your ads. You give $25.00 for a set 1,000 clicks. That is much easier then trying to figure out pay per click advertising! No more bid wars for first through third spot on search results. Save your money and come see for yourself.

Guide To Placemat Adbertising
Come see how you can make a great income from this type of advertising, just Click Here! for more information!

Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bri

by: Charles Essmeier

Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck’s Vioxx and Pfizer’s Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently. Studies showed that they increase the likelihood of strokes and heart attacks among patients that take them for prolonged periods of time. This represents an unusual move for a pharmaceutical company, as they tend to spend a large portion of their annual advertising budget on direct-to-consumer advertising.

It is possible that Bristol Myers recognizes that consumers are becoming concerned about new drugs being approved by the FDA and advertised heavily, only to find out later that the drugs have previously unknown and possibly dangerous side effects. Consumers have learned that advertising a drug as “new and improved” doesn’t necessarily mean that it is new, or improved, or even safe. In short, customers are suspicious of pharmaceutical advertising, and the drug companies are to be commended for taking notice of that fact.

Since 1997, drug companies have been allowed by U.S. law to advertise directly to consumers. This has led to an astonishing number of ads on television and radio, as consumers see ads showing one happy person after another. The ads suggest that the happiness shown is a result of the use of the product, and a voiceover quickly mumbles through the known, and sometimes lengthy, list of side effects. Patients are encouraged to speak with their doctor, and they have been doing so in record numbers. The problem, as Bristol Myers know realizes, is that consumers are well aware that the withdrawn Bextra and Vioxx were advertised as being safe. This has naturally led to a general suspicion of all advertised drugs, and Bristol Myers correctly sees that they could be the victims of a drug-company backlash, even if they didn’t manufacture any of the withdrawn products.

This will probably save Bristol Myers a lot of money in the short term, as their advertising would have largely gone to waste. The Food and Drug Administration is taking steps to make sure that the drugs that reach the U.S. market are safe, and in time, the public will again become more trusting of pharmaceutical advertising. In the meantime, TV viewers will be spared from having to watch the sometimes-cryptic drug ads, which often prompt questions of “What does this drug do?”

About the Author

©Copyright 2005 by Retro Marketing. Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.